Francisco Jorge Batel Marques
AuthID: R-000-PGC
51
TITLE: Application of the Number Needed to Treat (NNT) in Medical Literature: A Methodological Assessment Full Text
AUTHORS: Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
AUTHORS: Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
INDEXED IN: 
WOS
WOS52
TITLE: Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
AUTHORS: Diogo Mendes ; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2016, SOURCE: CNS DRUGS, VOLUME: 30, ISSUE: 10
AUTHORS: Diogo Mendes ; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2016, SOURCE: CNS DRUGS, VOLUME: 30, ISSUE: 10
53
TITLE: A systematic review of observational studies evaluating costs of adverse drug reactions Full Text
AUTHORS: Marques, FB; Penedones, A; Mendes, D; Alves, C;
PUBLISHED: 2016, SOURCE: ClinicoEconomics and Outcomes Research in CLINICOECONOMICS AND OUTCOMES RESEARCH, VOLUME: 8
AUTHORS: Marques, FB; Penedones, A; Mendes, D; Alves, C;
PUBLISHED: 2016, SOURCE: ClinicoEconomics and Outcomes Research in CLINICOECONOMICS AND OUTCOMES RESEARCH, VOLUME: 8
INDEXED IN: 
Scopus WOS 
Handle
Scopus WOS Handle54
TITLE: Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons
AUTHORS: Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2016, SOURCE: EXPERT OPINION ON DRUG SAFETY, VOLUME: 15, ISSUE: 10
AUTHORS: Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2016, SOURCE: EXPERT OPINION ON DRUG SAFETY, VOLUME: 15, ISSUE: 10
55
TITLE: Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis
AUTHORS: Carlos Alves; Inês Ribeiro; Ana Penedones; Diogo Mendes ; Francisco Batel Marques;
PUBLISHED: 2016, SOURCE: Ophthalmic Research, VOLUME: 57, ISSUE: 1
AUTHORS: Carlos Alves; Inês Ribeiro; Ana Penedones; Diogo Mendes ; Francisco Batel Marques;
PUBLISHED: 2016, SOURCE: Ophthalmic Research, VOLUME: 57, ISSUE: 1
INDEXED IN: Scopus
Scopus56
TITLE: Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit [Farmacovigilância em Portugal: Atividade da Unidade Regional do Centro] Full Text
AUTHORS: Batel Marques, F; Mendes, D ; Alves, C; Penedones, A; Dias, P; Martins, A; Santiago, LM; Fontes Ribeiro, C; Caramona, M; Macedo, T;
PUBLISHED: 2015, SOURCE: Acta Medica Portuguesa, VOLUME: 28, ISSUE: 2
AUTHORS: Batel Marques, F; Mendes, D ; Alves, C; Penedones, A; Dias, P; Martins, A; Santiago, LM; Fontes Ribeiro, C; Caramona, M; Macedo, T;
PUBLISHED: 2015, SOURCE: Acta Medica Portuguesa, VOLUME: 28, ISSUE: 2
INDEXED IN: Scopus
Scopus57
TITLE: Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit Full Text
AUTHORS: Francisco Batel Marques; Diogo Mendes; Carlos Alves; Ana Penedones; Patricia Dias; Angelina Martins; Luiz Miguel Santiago; Carlos Fontes Ribeiro; Margarida Caramona; Tice Macedo;
PUBLISHED: 2015, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 28, ISSUE: 2
AUTHORS: Francisco Batel Marques; Diogo Mendes; Carlos Alves; Ana Penedones; Patricia Dias; Angelina Martins; Luiz Miguel Santiago; Carlos Fontes Ribeiro; Margarida Caramona; Tice Macedo;
PUBLISHED: 2015, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 28, ISSUE: 2
INDEXED IN: WOS
WOS58
TITLE: Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone. NNH in the Post-marketing Safety Evaluation Full Text
AUTHORS: Diogo Mendes ; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2015, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 24, ISSUE: 12
AUTHORS: Diogo Mendes ; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2015, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 24, ISSUE: 12
59
TITLE: COSTS OF ADVERSE DRUG EVENTS: SYSTEMATIC REVIEW Full Text
AUTHORS: Batel Marques, F; Penedones, A; Alves, C; Mendes, D ;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Batel Marques, F; Penedones, A; Alves, C; Mendes, D ;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
60
TITLE: OCULAR ADVERSE EVENTS INDUCED BY DRUGS: A REVIEW OF THE SAFETY ALERTS ISSUED BY HEALTH REGULATORY AUTHORITIES Full Text
AUTHORS: Penedones, A; Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2015, SOURCE: 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics in CLINICAL THERAPEUTICS, VOLUME: 37, ISSUE: 8
AUTHORS: Penedones, A; Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2015, SOURCE: 12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics in CLINICAL THERAPEUTICS, VOLUME: 37, ISSUE: 8
INDEXED IN: WOS 
CrossRef
WOS CrossRef